Navigation Links
ASM Recommends Nasopharyngeal Flocked Swabs as the Specimen of Choice for Influenza A Testing (Including H1N1)

MURRIETA, Calif., Oct. 27 /PRNewswire/ -- Preparing for this flu season, the American Society for Microbiology (ASM) PSAB Committee on Laboratory Practices has recently published a new interim algorithm providing guidance to clinical laboratories responsible for testing patients with respiratory illness for Influenza A, including H1N1. The document provides a detailed flowchart that guides microbiologists and physicians through patient assessment and differential diagnosis, and provides recommendations for confirmatory testing. The algorithm focuses particular attention on the critical first step, collection of an optimal specimen, because this step determines the sensitivity and accuracy of the diagnosis. The ASM recommends Nasopharyngeal (NP) Flocked Swabs, patented and manufactured by Copan, as the specimen of choice for Influenza testing. In addition to NP Flocked Swabs, NP aspirates, NP washes, or nasal aspirates are also recommended for testing.

Until the introduction of Copan Flocked Swabs, NP aspirates and washes had been the gold standard for specimen collection for respiratory virus diagnostics because traditional fiber swabs are inferior in terms of the amount of patient sample they collect and the ability to transfer that sample into the test platform. Conversely, the aspirate or wash procedure rinses and removes large quantities of patient sample. The widespread endorsement of Flocked Swabs is attributed to the unique design of the applicator which enables improved sample collection and transfer. The success of Flocked Swabs for Influenza testing is due to a combination of a brush-like action that dislodges large numbers of infected cells and capillary hydraulics, which draws liquid sample between the perpendicular fibers. The Flocked Swabs have a unique mechanical and hydrophilic advantage over any other swab technology. Unlike fiber swabs, which absorb well but entrap the sample in a mattress core, and foam swabs, which are hydrophobic and have poor sample uptake, Flocked Swabs collect a large sample volume -- almost four times more than foam swabs -- and then spontaneously release it into any test system.

Endorsement of Copan Nasopharyngeal Flocked Swabs as the specimen of choice for Influenza testing follows the publication of numerous clinical studies that demonstrate equivalent or better test results when compared with NP aspirates or washes. Copan Flocked Swabs are easier to use, cause less patient discomfort and can be used for sample collection at remote centers, whereas NP aspirates and washes must be performed in a hospital setting by trained personnel with material cost that exceeds that of Flocked Swabs. Copan Flocked Swabs are the best swab technology for Influenza testing that equates to the high specimen yields that laboratory professionals are accustomed to with NP aspirates and washes.

About Copan Diagnostics, Inc.

With a reputation for innovation in preanalytics, Copan is the leading manufacturer of collection and transport systems in the world. Copan offers a complete range of microbial sampling products used for traditional culture analysis and molecular diagnostic assays. For more information, visit

SOURCE Copan Diagnostics, Inc.

SOURCE Copan Diagnostics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women
2. Data Safety Monitoring Board Unanimously Recommends Continuation of Delcaths Phase III Clinical Trial
3. FDA Advisory Panel Recommends Approval of the SEDASYS(R) System
4. HIV/AIDS Research Network Recommends Use of Abbott RealTime Viral Load Test for NIH-Sponsored Clinical Trials
5. FDA Advisory Committee Recommends Approval of Multaq(R) (dronedarone)
6. Task Force Recommends Using Aspirin to Prevent Cardiovascular Disease When the Benefits Outweigh the Harms
7. Independent Data Monitoring Committee Recommends Resuming Enrollment of Non-Squamous NSCLC Patients in the Motesanib MONET1 Trial
8. CHMP Recommends Approval in the European Union (EU) for New Options for Patients With Certain Primary Brain Tumors
9. Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout
10. CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients
11. Task Force Recommends Screening for Hearing Loss in All Newborns
Post Your Comments:
(Date:11/30/2015)... Next week, December 2-3, BIOMEDevice San ... co-located events covering the latest in Medtech innovation, Wearable ... draw more than 3,000 design industry professionals to the ... events, combined show floor will host more than 300 ... --> --> BIOMEDevice features suppliers in ...
(Date:11/30/2015)...  IBA Molecular North America, Inc. (IBAMNA), a U.S. ... that as of January 1, 2016, it will do ... to rebrand the company reflects a refined vision for ... close relationship with Zevacor Molecular.  Both IBAMNA and Zevacor ... Peter Burke , Vice President Sales ...
(Date:11/30/2015)... , Nov. 30, 2015 Nautilus Medical Inc. ... Image Management platform ( ). The release of ... from RSNA 2015 (Radiology Society North America) in ... in the U.S. --> ... that enables access to radiology studies worldwide via a ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... , ... According to Los Angeles bariatric surgeon Michael Feiz, M.D., F.A.C.S., many ... real hunger, but instead by a hormone called ghrelin which (often prematurely) signals ... are aware that weight loss surgery can help patients lose weight by restricting the ...
(Date:11/30/2015)... Miami, FL (PRWEB) , ... November 30, 2015 ... ... added a comparison chart and ingredient list of its hemorrhoid ointment to its ... “fast, effective pain relief for people suffering from hemorrhoids. Adding the comparison chart ...
(Date:11/30/2015)... ... November 30, 2015 , ... Using a combination of two blood sugar tests ... adults, according to a new study by researchers at the School of Public Health ... Adults: Using Combinations of Blood Glucose Tests ,” published in Frontiers in Public Health, ...
(Date:11/30/2015)... ... November 30, 2015 , ... The recently ... Poison Data System (NPDS) reveals that in 2014, someone called a poison center ... two million of which were human exposure cases. , The American Association of ...
(Date:11/30/2015)... Reading, PA (PRWEB) , ... November 30, 2015 ... ... Ashland Specialty Ingredients (ASI) as their exclusive channel partner for the Nutraceutical Specialties ... supplements markets in the US, effective immediately. , “We are pleased to ...
Breaking Medicine News(10 mins):